4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-035701
Chief Financial Officer sold 30,000 shares at an average $39.35 ($1,180,518)
- Chief Financial Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-06-08 | Option exercise | +21,250 | $6.32 | $134,300 | 22,250 | D: show line 1 in the form |
| Cohen Chad M Chief Financial Officer | 2020-06-08 | Sale | −18,805 | $38.99 | $733,207 | 3,445 | D: show line 2 in the form |
| Cohen Chad M Chief Financial Officer | 2020-06-08 | Sale | −2,445 | $39.80 | $97,311 | 1,000 | D: show line 3 in the form |
| Cohen Chad M Chief Financial Officer | 2020-06-09 | Option exercise | +8,750 | $6.32 | $55,300 | 9,750 | D: show line 4 in the form |
| Cohen Chad M Chief Financial Officer | 2020-06-09 | Sale | −8,750 | $40.00 | $350,000 | 1,000 | D: show line 5 in the form |
| Open-market sales · 30,000 sh · avg $39.35 · $1,180,518 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-06-08 | Option exercise · Stock Option (Right To Buy) | −21,250 | 678,750 | D: show line 6 in the form | ||
| Cohen Chad M Chief Financial Officer | 2020-06-09 | Option exercise · Stock Option (Right to Buy) | −8,750 | 670,000 | D: show line 7 in the form |
Loading xslF345X03/doc4.xml…